Stoneridge Investment Partners’s Gilead Sciences GILD Stock Holding History

Stoneridge Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,766	Closed	-$452K	–	122
2020 Q4	$452K	Sell	7,766 -200	-3%	-$12.1K	0.26%	84
2020 Q3	$503K	Sell	7,966 -21,641	-73%	-$1.5M	0.33%	78
2020 Q2	$2.28M	Buy	+29,607	New	+$2.27M	0.96%	31
2020 Q1	–	Sell	-52,420	Closed	-$3.41M	–	126
2019 Q4	$3.41M	Sell	52,420 -13,951	-21%	-$909K	1.15%	26
2019 Q3	$4.21M	Sell	66,371 -24,794	-27%	-$1.62M	1.55%	14
2019 Q2	$6.16M	Buy	91,165 +8,059	+10%	+$530K	2.19%	8
2019 Q1	$5.4M	Buy	+83,106	New	+$5.52M	1.59%	14
2017 Q3	–	Sell	-283,256	Closed	-$20M	–	262
2017 Q2	$20M	Buy	283,256 +212,392	+300%	+$14.1M	2.99%	3
2017 Q1	$4.81M	Buy	+70,864	New	+$4.98M	0.65%	49
2015 Q2	–	Sell	-73,318	Closed	-$7.2M	–	287
2015 Q1	$7.2M	Buy	73,318 +25,364	+53%	+$2.58M	0.84%	27
2014 Q4	$4.52M	Buy	+47,954	New	+$4.96M	0.6%	57
2014 Q2	–	Sell	-53,080	Closed	-$3.76M	–	238
2014 Q1	$3.76M	Buy	+53,080	New	+$4.16M	0.73%	52

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Stoneridge Investment Partners's GILD Position: Q1 2021 in Review

Stoneridge Investment Partners sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 7,766 shares — an estimated $452K sold.

Stoneridge Investment Partners first reported a position in GILD in Q1 2014 and held it in 12 quarters. The position peaked at $20M in Q2 2017. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

Stoneridge Investment Partners reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
Stoneridge Investment Partners sold 7,766 Gilead Sciences shares in Q1 2021, an estimated $452K.
Stoneridge Investment Partners first reported a position in Gilead Sciences in Q1 2014 and held it in 12 quarters.
Stoneridge Investment Partners's Gilead Sciences position peaked at $20M in Q2 2017.
1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Stoneridge Investment Partners's 13F filing for Q1 2021, filed 30 Apr 2021.